Hochschulschrift
New drugs in prevention of experimental corneal graft rejection
- Weitere Titel
-
Neue Medikamente für die Vermeidung von experimenteller Hornhauttransplantatabstoßung
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Medizinische Fakultät Charité - Universitätsmedizin Berlin, Diss., 2014
- Schlagwort
-
Augenheilkunde
Augenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (wann)
-
2014
- Urheber
- URN
-
urn:nbn:de:kobv:188-fudissthesis000000097093-4
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Otasevic-Wieschalla, Ljiljana
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Entstanden
- 2014
Ähnliche Objekte (12)
Prognostic factors for corneal graft recovery after severe corneal graft rejection following penetrating keratoplasty
Presumably Corneal Graft Rejection after COVID-19 Vaccination
Corneal Graft Rejection after Descemet’s Membrane Endothelial Keratoplasty with Peripheral Anterior Synechiae
Machine learning methods to identify risk factors for corneal graft rejection in keratoconus
Lymph node removal enhances corneal graft survival in mice at high risk of rejection
Semaphorin 3F modulates corneal lymphangiogenesis and promotes corneal graft survival
Complement activation during acute graft rejection after renal transplantation
Partial thickness corneal tissue as a patch graft material for prevention of glaucoma drainage device exposure
The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis
Harnessing Tumor Cell‐Derived Exosomes for Immune Rejection Management in Corneal Transplantation
Liver graft rejection following immune checkpoint inhibitors treatment: a review
Antilymphangiogenic therapies to promote high-risk corneal graft survival
Prognostic factors for corneal graft recovery after severe corneal graft rejection following penetrating keratoplasty
Presumably Corneal Graft Rejection after COVID-19 Vaccination
Corneal Graft Rejection after Descemet’s Membrane Endothelial Keratoplasty with Peripheral Anterior Synechiae
Machine learning methods to identify risk factors for corneal graft rejection in keratoconus
Lymph node removal enhances corneal graft survival in mice at high risk of rejection
Semaphorin 3F modulates corneal lymphangiogenesis and promotes corneal graft survival
Complement activation during acute graft rejection after renal transplantation
Partial thickness corneal tissue as a patch graft material for prevention of glaucoma drainage device exposure
The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis
Harnessing Tumor Cell‐Derived Exosomes for Immune Rejection Management in Corneal Transplantation
Liver graft rejection following immune checkpoint inhibitors treatment: a review
Antilymphangiogenic therapies to promote high-risk corneal graft survival
Prognostic factors for corneal graft recovery after severe corneal graft rejection following penetrating keratoplasty
Presumably Corneal Graft Rejection after COVID-19 Vaccination
Corneal Graft Rejection after Descemet’s Membrane Endothelial Keratoplasty with Peripheral Anterior Synechiae
Machine learning methods to identify risk factors for corneal graft rejection in keratoconus
Lymph node removal enhances corneal graft survival in mice at high risk of rejection
Semaphorin 3F modulates corneal lymphangiogenesis and promotes corneal graft survival
Complement activation during acute graft rejection after renal transplantation
Partial thickness corneal tissue as a patch graft material for prevention of glaucoma drainage device exposure
The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis
Harnessing Tumor Cell‐Derived Exosomes for Immune Rejection Management in Corneal Transplantation
Liver graft rejection following immune checkpoint inhibitors treatment: a review